CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 136 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 12.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $491,000 | -1.6% | 75,000 | 0.0% | 0.01% | -50.0% |
| Q3 2020 | $499,000 | -20.2% | 75,000 | 0.0% | 0.01% | -41.2% |
| Q2 2020 | $625,000 | -18.5% | 75,000 | -25.0% | 0.02% | -46.9% |
| Q1 2020 | $767,000 | -7.7% | 100,000 | 0.0% | 0.03% | +18.5% |
| Q4 2019 | $831,000 | +12.6% | 100,000 | 0.0% | 0.03% | -6.9% |
| Q3 2019 | $738,000 | -47.4% | 100,000 | -20.0% | 0.03% | -12.1% |
| Q2 2019 | $1,403,000 | +4.4% | 125,000 | 0.0% | 0.03% | -21.4% |
| Q1 2019 | $1,344,000 | -28.8% | 125,000 | 0.0% | 0.04% | -44.0% |
| Q4 2018 | $1,888,000 | -18.4% | 125,000 | 0.0% | 0.08% | +50.0% |
| Q3 2018 | $2,313,000 | – | 125,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |